CC BY-NC-ND 4.0 · Asian J Neurosurg 2022; 17(02): 199-208
DOI: 10.1055/s-0042-1750784
Special Report

Patients with Invasive Tumors and eNOS Gene Polymorphisms with Subarachnoid Hemorrhage Tend to Have Poorer Prognosis

Hardik Lalit Siroya
1   Department of Neurosurgery, National Institute of Mental Health and Neuro Sciences (NIMHANS), Bengaluru, Karnataka, India
,
Bhagavatula Indira Devi
1   Department of Neurosurgery, National Institute of Mental Health and Neuro Sciences (NIMHANS), Bengaluru, Karnataka, India
,
Prasanthi Aripirala
2   Department of Pediatrics, National Institute of Mental Health and Neuro Sciences (NIMHANS), Bengaluru, Karnataka, India
,
Shruthi Shimoga Ramesh
1   Department of Neurosurgery, National Institute of Mental Health and Neuro Sciences (NIMHANS), Bengaluru, Karnataka, India
,
Dhananjaya Ishwar Bhat
1   Department of Neurosurgery, National Institute of Mental Health and Neuro Sciences (NIMHANS), Bengaluru, Karnataka, India
,
Dhaval Prem Shukla
1   Department of Neurosurgery, National Institute of Mental Health and Neuro Sciences (NIMHANS), Bengaluru, Karnataka, India
,
Subhash Kanti Konar
1   Department of Neurosurgery, National Institute of Mental Health and Neuro Sciences (NIMHANS), Bengaluru, Karnataka, India
,
Rita Christopher
3   Department of Neurochemistry, National Institute of Mental Health and Neuro Sciences (NIMHANS), Bengaluru, Karnataka, India
› Institutsangaben
Funding We thank the Indian Council of Medical Research for funding.

Abstract

Context Endothelial nitric oxide synthase (eNOS) gene polymorphisms are found to predict predisposition to aneurysmal rupture and development of vasospasm in a patient of subarachnoid hemorrhage (SAH). eNOS gene polymorphisms are also found to predict invasiveness of malignant cells. Studies are not available in literature to describe the effect of eNOS gene polymorphisms and correlation between aneurysm and carcinoma. This study aims to investigate whether positive cancer history influences clinical outcome following SAH and eNOS gene polymorphisms.

Materials and Methods The eNOS gene polymorphisms were analyzed in seven consecutive patients (mean age, 52.28 ± 20 years) with a diagnosis of invasive systemic tumors from 2011 to 2017. The eNOS 4a/4b eNOS -786T> eNOS894G > T polymorphisms of the eNOS gene were determined by polymerase chain reaction and restriction fragment length polymorphism.

Results Seven patients of aneurysmal SAH in association with malignancies were studied for eNOS polymorphisms expression and outcome. Three patients had carcinoma cervix: one patient of carcinoma breast and one each of transitional cell carcinoma of urinary bladder, spindle cell carcinoma of left kidney, and untreated patient of atypical pituitary (adenoma). A genotype study of eNOS gene polymorphisms in these patients shows common polymorphisms are involved in the determination of disease progression in malignancies and aneurysmal SAH.

Conclusion Patients who expressed 4ab, eNOS -786T > TT/CC/TC, eNOS894G > T GG/GT polymorphisms did better than patients who expressed only 4bb, though both were associated with poor prognosis.



Publikationsverlauf

Artikel online veröffentlicht:
24. August 2022

© 2022. Asian Congress of Neurological Surgeons. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 Lee T-H, Huang S-C, Su T-M, Yang K-Y, Rau C-S. Multiple cerebral aneurysms and brain metastasis from primary cardiac myxosarcoma: a case report and literature review. Chang Gung Med J 2011; 34 (03) 315-319
  • 2 Nomura R, Yoshida D, Kim K, Kobayashi S, Teramoto A. Intracerebral hemorrhage caused by a neoplastic aneurysm from pleomorphic lung carcinoma. Neurol Med Chir (Tokyo) 2009; 49 (01) 33-36
  • 3 Cheng WY, Shen CC. Minimally invasive approaches to treat simultaneous occurrence of glioblastoma multiforme and intracranial aneurysm – case report. Minim Invasive Neurosurg 2004; 47 (03) 181-185
  • 4 Cheon KT, Choi KH, Lee HB, Park SK, Rhee YK, Lee YC. Gene polymorphisms of endothelial nitric oxide synthase and angiotensin-converting enzyme in patients with lung cancer. Lung 2000; 178 (06) 351-360
  • 5 Ivanović BA, Tadić M, Vraneš M, Orbović B. Cerebral aneurysm associated with cardiac myxoma: case report. Bosn J Basic Med Sci 2011; 11 (01) 65-68
  • 6 Spetzger U, Mull M, Sure U, Gilsbach J. Subarachnoid and intraventricular hemorrhage caused by hypernephroma metastasis, accompanied by innocent bilateral posterior communicating artery aneurysms. Surg Neurol 1995; 44 (03) 275-278
  • 7 Yamamoto F, Maruiwa M, Kanetani K, Matsuo H, Shigemori M, Kuramoto S. [Coexistence of multiple metastatic brain tumors from thyroid carcinoma and cerebral aneurysms]. No Shinkei Geka 1990; 18 (04) 361-365
  • 8 Matsko DE, Babaĭtsev AV, Glukhovets BI, Litvak EA. [Intracranial oncogenic aneurysm]. Arkh Patol 1989; 51 (02) 72-75
  • 9 Honda M, Kamada K, Nakata Y, Harada T, Iwanaga H, Tsukamoto M. [The association of cerebral aneurysm with malignant brain tumor–report of a case (author's transl)]. No Shinkei Geka 1980; 8 (11) 1065-1070
  • 10 Pant B, Arita K, Kurisu K, Tominaga A, Eguchi K, Uozumi T. Incidence of intracranial aneurysm associated with pituitary adenoma. Neurosurg Rev 1997; 20 (01) 13-17
  • 11 Javalkar V, Guthikonda B, Vannemreddy P, Nanda A. Association of meningioma and intracranial aneurysm: report of five cases and review of literature. Neurol India 2009; 57 (06) 772-776
  • 12 Shibahara I, Watanabe T, Ezura M. et al. Clinical features of subarachnoid hemorrhage in patients with positive cancer history. J Neurooncol 2016; 128 (01) 129-136
  • 13 Maheshwari A, Gupta S, Wuntkal R, Kulkarni Y, Tongaonkar HM. Brain metastasis from cervical carcinoma–a case report. J Medscape Gen Med 2005
  • 14 Duarte FHG, Machado MC, Lima JR, Salgado LR. Severe hyperprolactinemia associated with internal carotid artery aneurysm: differential diagnosis between prolactinoma and hypothalamic-pituitary disconnection. Arq Bras Endocrinol Metabol 2008; 52 (07) 1189-1193
  • 15 Wadasadawala T, Gupta S, Bagul V, Patil N. Brain metastases from breast cancer: management approach. J Cancer Res Ther 2007; 3 (03) 157-165
  • 16 Koppelmans V, Schagen SB, Poels MMF. et al. Incidental findings on brain magnetic resonance imaging in long-term survivors of breast cancer treated with adjuvant chemotherapy. Eur J Cancer 2011; 47 (17) 2531-2536
  • 17 Alexander S, Poloyac S, Hoffman L. et al. Endothelial nitric oxide synthase tagging single nucleotide polymorphisms and recovery from aneurysmal subarachnoid hemorrhage. Biol Res Nurs 2009; 11 (01) 42-52
  • 18 Gao X, Wang J, Wang W, Wang M, Zhang J. eNOS genetic polymorphisms and cancer risk: a meta-analysis and a case-control study of breast cancer. Medicine (Baltimore) 2015; 94 (26) e972
  • 19 Khurana VG, Sohni YR, Mangrum WI. et al. Endothelial nitric oxide synthase gene polymorphisms predict susceptibility to aneurysmal subarachnoid hemorrhage and cerebral vasospasm. J Cereb Blood Flow Metab 2004; 24 (03) 291-297
  • 20 Ko NU, Rajendran P, Kim H. et al. Endothelial nitric oxide synthase polymorphism (-786T->C) and increased risk of angiographic vasospasm after aneurysmal subarachnoid hemorrhage. Stroke 2008; 39 (04) 1103-1108
  • 21 Krischek B, Kasuya H, Akagawa H. et al. Using endothelial nitric oxide synthase gene polymorphisms to identify intracranial aneurysms more prone to rupture in Japanese patients. J Neurosurg 2006; 105 (05) 717-722
  • 22 Li P, Ma LT, Zhang XZ, Gong J, Mo XH. [Risk of cerebral vasospasm following subarachnoid hemorrhage is associated with endothelial nitric oxide synthase gene polymorphism]. Nan Fang Yi Ke Da Xue Xue Bao 2009; 29 (02) 280-283
  • 23 McColgan P, Thant KZ, Sharma P. The genetics of sporadic ruptured and unruptured intracranial aneurysms: a genetic meta-analysis of 8 genes and 13 polymorphisms in approximately 20,000 individuals. J Neurosurg 2010; 112 (04) 714-721
  • 24 Murthy SB, Shastri A, Merkler AE. et al. Intracerebral hemorrhage outcomes in patients with systemic cancer. J Stroke Cerebrovasc Dis 2016; 25 (12) 2918-2924
  • 25 Navi BB, Reichman JS, Berlin D. et al. Intracerebral and subarachnoid hemorrhage in patients with cancer. Neurology 2010; 74 (06) 494-501
  • 26 Navi BB, Reiner AS, Kamel H. et al. Association between incident cancer and subsequent stroke. Ann Neurol 2015; 77 (02) 291-300
  • 27 Ozüm U, Bolat N, Gül E, Özdemir O. Endothelial nitric oxide synthase gene [G894T] polymorphism as a possible risk factor in aneurysmal subarachnoid haemorrhage. Acta Neurochir (Wien) 2008; 150 (01) 57-61 , discussion 62
  • 28 Paschoal EHA, Yamaki VN, Teixeira RKC. et al. Relationship between endothelial nitric oxide synthase (eNOS) and natural history of intracranial aneurysms: meta-analysis. Neurosurg Rev 2018; 41 (01) 87-94
  • 29 Polat F, Diler SB, Azazi İ, Öden A. T-786C, G894T, and intron 4 VNTR (4a/b) polymorphisms of the endothelial nitric oxide synthase gene in bladder cancer cases. Asian Pac J Cancer Prev 2015; 16 (06) 2199-2202
  • 30 Rosalind Lai PM, Du R. Role of genetic polymorphisms in predicting delayed cerebral ischemia and radiographic vasospasm after aneurysmal subarachnoid hemorrhage: a meta-analysis. World Neurosurg 2015; 84 (04) 933-41.e2
  • 31 Staalsø JM, Edsen T, Kotinis A, Romner B, Springborg JB, Olsen NV. Association of the NOS3 intron-4 VNTR polymorphism with aneurysmal subarachnoid hemorrhage. J Neurosurg 2014; 121 (03) 587-592
  • 32 Starke RM, Kim GH, Komotar RJ. et al. Endothelial nitric oxide synthase gene single-nucleotide polymorphism predicts cerebral vasospasm after aneurysmal subarachnoid hemorrhage. J Cereb Blood Flow Metab 2008; 28 (06) 1204-1211
  • 33 Velander AJ, DeAngelis LM, Navi BB. Intracranial hemorrhage in patients with cancer. Curr Atheroscler Rep 2012; 14 (04) 373-381
  • 34 Verim L, Toptas B, Ozkan NE. et al. Possible relation between the NOS3 gene GLU298ASP polymorphism and bladder cancer in Turkey. Asian Pac J Cancer Prev 2013; 14 (02) 665-668
  • 35 Wu X, Wang Z-F, Xu Y, Ren R, Heng B-L, Su Z-X. Association between three eNOS polymorphisms and cancer risk: a meta-analysis. Asian Pac J Cancer Prev 2014; 15 (13) 5317-5324
  • 36 Zhang L, Chen LM, Wang MN. et al. The G894t, T-786c and 4b/a polymorphisms in Enos gene and cancer risk: a meta-analysis. J Evid Based Med 2014; 7 (04) 263-269
  • 37 Khalkhali-Ellis Z, Hendrix MJC. Nitric oxide regulation of Maspin expression in normal mammary epithelial and breast cancer cells. Am J Pathol 2003; 162 (05) 1411-1417
  • 38 Schneider BP, Radovich M, Sledge GW. et al. Association of polymorphisms of angiogenesis genes with breast cancer. Breast Cancer Res Treat 2008; 111 (01) 157-163
  • 39 Yeh C-C, Santella RM, Hsieh L-L, Sung F-C, Tang R. An intron 4 VNTR polymorphism of the endothelial nitric oxide synthase gene is associated with early-onset colorectal cancer. Int J Cancer 2009; 124 (07) 1565-1571
  • 40 Khurana VG, Meissner I, Sohni YR. et al. The presence of tandem endothelial nitric oxide synthase gene polymorphisms identifying brain aneurysms more prone to rupture. J Neurosurg 2005; 102 (03) 526-531